Cowen Prime Advisors’s Celgene Corp CELG Stock Holding History

Cowen Prime Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,000	Closed	-$209K	–	266
2016 Q3	$209K	Hold	2,000	–	–	0.09%	108
2016 Q2	$197K	Hold	2,000	–	–	0.1%	94
2016 Q1	$200K	Hold	2,000	–	–	0.09%	94
2015 Q4	$240K	Hold	2,000	–	–	0.11%	89
2015 Q3	$216K	Buy	+2,000	New	+$248K	0.1%	98
2015 Q2	–	Sell	-5,700	Closed	-$657K	–	343
2015 Q1	$657K	Buy	5,700 +1,100	+24%	+$131K	0.27%	56
2014 Q4	$515K	Buy	4,600 +450	+11%	+$47.5K	0.2%	64
2014 Q3	$393K	Sell	4,150 -1,850	-31%	-$167K	0.17%	72
2014 Q2	$515K	Buy	6,000 +700	+13%	+$53.2K	0.2%	50
2014 Q1	$370K	Buy	5,300 +3,300	+165%	+$261K	0.14%	67
2013 Q4	$169K	Sell	2,000 -1,390	-41%	-$110K	0.07%	109
2013 Q3	$266K	Sell	3,390 -2,000	-37%	-$140K	0.1%	99
2013 Q2	$317K	Buy	+5,390	New	+$324K	0.13%	83

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cowen Prime Advisors's CELG Position: Q4 2016 in Review

Cowen Prime Advisors sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 2,000 shares — an estimated $209K sold.

Cowen Prime Advisors first reported a position in CELG in Q2 2013 and held it in 13 quarters. The position peaked at $657K in Q1 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

Cowen Prime Advisors reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
Cowen Prime Advisors sold 2,000 Celgene Corp shares in Q4 2016, an estimated $209K.
Cowen Prime Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 13 quarters.
Cowen Prime Advisors's Celgene Corp position peaked at $657K in Q1 2015.
1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Cowen Prime Advisors's 13F filing for Q4 2016, filed 9 Feb 2017.